SpaceX explores healthcare via Starlink, AI, and orbital drug manufacturing in SEC filing ahead of mega-IPO

Ahead of its mega-IPO, SpaceX revealed healthcare ambitions in its SEC filing, highlighting Starlink's role in improving remote healthcare access in underserved areas. The company also envisions manufacturing pharmaceuticals in orbit, leveraging microgravity to enhance drug properties, a concept tested by other pharma firms. Additionally, SpaceX sees AI as a key tool for accelerating scientific discovery and medical diagnosis, though its AI chatbot Grok has faced challenges in providing accurate health advice. These moves signal SpaceX's potential to expand beyond aerospace into healthcare innovation.